Literature DB >> 27009605

Primitive Embryonic Macrophages are Required for Coronary Development and Maturation.

Jamison Leid1, Joana Carrelha1, Hanane Boukarabila1, Slava Epelman1, Sten E W Jacobsen1, Kory J Lavine2.   

Abstract

RATIONALE: It is now recognized that macrophages residing within developing and adult tissues are derived from diverse progenitors including those of embryonic origin. Although the functions of macrophages in adult organisms are well studied, the functions of macrophages during organ development remain largely undefined. Moreover, it is unclear whether distinct macrophage lineages have differing functions.
OBJECTIVE: To address these issues, we investigated the functions of macrophage subsets resident within the developing heart, an organ replete with embryonic-derived macrophages. METHODS AND
RESULTS: Using a combination of flow cytometry, immunostaining, and genetic lineage tracing, we demonstrate that the developing heart contains a complex array of embryonic macrophage subsets that can be divided into chemokine (C-C motif) receptor 2(-) and chemokine (C-C motif) receptor 2(+) macrophages derived from primitive yolk sac, recombination activating gene 1(+) lymphomyeloid, and Fms-like tyrosine kinase 3(+) fetal monocyte lineages. Functionally, yolk sac-derived chemokine (C-C motif) receptor 2(-) macrophages are instrumental in coronary development where they are required for remodeling of the primitive coronary plexus. Mechanistically, chemokine (C-C motif) receptor 2(-) macrophages are recruited to coronary blood vessels at the onset of coronary perfusion where they mediate coronary plexus remodeling through selective expansion of perfused vasculature. We further demonstrate that insulin like growth factor signaling may mediate the proangiogenic properties of embryonic-derived macrophages.
CONCLUSIONS: Together, these findings demonstrate that the embryonic heart contains distinct lineages of embryonic macrophages with unique functions and reveal a novel mechanism that governs coronary development.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  flow cytometry; fms-like tyrosine kinase 3; macrophages; monocytes; yolk sac

Mesh:

Substances:

Year:  2016        PMID: 27009605      PMCID: PMC5567774          DOI: 10.1161/CIRCRESAHA.115.308270

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  43 in total

Review 1.  Signaling during epicardium and coronary vessel development.

Authors:  José María Pérez-Pomares; José Luis de la Pompa
Journal:  Circ Res       Date:  2011-12-09       Impact factor: 17.367

Review 2.  Epicardial-myocardial signaling directing coronary vasculogenesis.

Authors:  Harold E Olivey; Eric C Svensson
Journal:  Circ Res       Date:  2010-03-19       Impact factor: 17.367

3.  Motoneurons and oligodendrocytes are sequentially generated from neural stem cells but do not appear to share common lineage-restricted progenitors in vivo.

Authors:  Sen Wu; Yuanyuan Wu; Mario R Capecchi
Journal:  Development       Date:  2006-01-11       Impact factor: 6.868

4.  All hematopoietic cells develop from hematopoietic stem cells through Flk2/Flt3-positive progenitor cells.

Authors:  Scott W Boyer; Aaron V Schroeder; Stephanie Smith-Berdan; E Camilla Forsberg
Journal:  Cell Stem Cell       Date:  2011-07-08       Impact factor: 24.633

5.  Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis.

Authors:  Simon Yona; Ki-Wook Kim; Yochai Wolf; Alexander Mildner; Diana Varol; Michal Breker; Dalit Strauss-Ayali; Sergey Viukov; Martin Guilliams; Alexander Misharin; David A Hume; Harris Perlman; Bernard Malissen; Elazar Zelzer; Steffen Jung
Journal:  Immunity       Date:  2012-12-27       Impact factor: 31.745

6.  C-Myb(+) erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages.

Authors:  Guillaume Hoeffel; Jinmiao Chen; Yonit Lavin; Donovan Low; Francisca F Almeida; Peter See; Anna E Beaudin; Josephine Lum; Ivy Low; E Camilla Forsberg; Michael Poidinger; Francesca Zolezzi; Anis Larbi; Lai Guan Ng; Jerry K Y Chan; Melanie Greter; Burkhard Becher; Igor M Samokhvalov; Miriam Merad; Florent Ginhoux
Journal:  Immunity       Date:  2015-04-21       Impact factor: 31.745

7.  Myocardin-related transcription factors control the motility of epicardium-derived cells and the maturation of coronary vessels.

Authors:  Michael A Trembley; Lissette S Velasquez; Karen L de Mesy Bentley; Eric M Small
Journal:  Development       Date:  2015-01-01       Impact factor: 6.868

8.  Macrophages are required for neonatal heart regeneration.

Authors:  Arin B Aurora; Enzo R Porrello; Wei Tan; Ahmed I Mahmoud; Joseph A Hill; Rhonda Bassel-Duby; Hesham A Sadek; Eric N Olson
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

9.  In vivo silencing of the transcription factor IRF5 reprograms the macrophage phenotype and improves infarct healing.

Authors:  Gabriel Courties; Timo Heidt; Matthew Sebas; Yoshiko Iwamoto; Derrick Jeon; Jessica Truelove; Benoit Tricot; Greg Wojtkiewicz; Partha Dutta; Hendrik B Sager; Anna Borodovsky; Tatiana Novobrantseva; Boris Klebanov; Kevin Fitzgerald; Daniel G Anderson; Peter Libby; Filip K Swirski; Ralph Weissleder; Matthias Nahrendorf
Journal:  J Am Coll Cardiol       Date:  2013-12-18       Impact factor: 24.094

10.  Ly-6Chigh monocytes depend on Nr4a1 to balance both inflammatory and reparative phases in the infarcted myocardium.

Authors:  Ingo Hilgendorf; Louisa M S Gerhardt; Timothy C Tan; Carla Winter; Tobias A W Holderried; Benjamin G Chousterman; Yoshiko Iwamoto; Ronglih Liao; Andreas Zirlik; Marielle Scherer-Crosbie; Catherine C Hedrick; Peter Libby; Matthias Nahrendorf; Ralph Weissleder; Filip K Swirski
Journal:  Circ Res       Date:  2014-03-13       Impact factor: 17.367

View more
  81 in total

Review 1.  Why some organ allografts are tolerated better than others: new insights for an old question.

Authors:  Travis D Hull; Gilles Benichou; Joren C Madsen
Journal:  Curr Opin Organ Transplant       Date:  2019-02       Impact factor: 2.640

Review 2.  Modifiable Cardiovascular Risk, Hematopoiesis, and Innate Immunity.

Authors:  Maximilian J Schloss; Filip K Swirski; Matthias Nahrendorf
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

3.  Deficiency of GATA3-Positive Macrophages Improves Cardiac Function Following Myocardial Infarction or Pressure Overload Hypertrophy.

Authors:  Mingjie Yang; Lei Song; Lai Wang; Ada Yukht; Haley Ruther; Fuqiang Li; Minghui Qin; Homayon Ghiasi; Behrooz G Sharifi; Prediman K Shah
Journal:  J Am Coll Cardiol       Date:  2018-08-21       Impact factor: 24.094

4.  Novel functions of macrophages in the heart: insights into electrical conduction, stress, and diastolic dysfunction.

Authors:  Florian Leuschner; Matthias Nahrendorf
Journal:  Eur Heart J       Date:  2020-03-01       Impact factor: 29.983

Review 5.  Macrophages in Heart Failure with Reduced versus Preserved Ejection Fraction.

Authors:  Matthew DeBerge; Sanjiv J Shah; Lisa Wilsbacher; Edward B Thorp
Journal:  Trends Mol Med       Date:  2019-02-05       Impact factor: 11.951

6.  Myeloid cells in cardiovascular organs.

Authors:  M Nahrendorf
Journal:  J Intern Med       Date:  2018-12-25       Impact factor: 8.989

Review 7.  Hematopoiesis and Cardiovascular Disease.

Authors:  Wolfram C Poller; Matthias Nahrendorf; Filip K Swirski
Journal:  Circ Res       Date:  2020-04-09       Impact factor: 17.367

Review 8.  Resident and Monocyte-Derived Macrophages in Cardiovascular Disease.

Authors:  Lisa Honold; Matthias Nahrendorf
Journal:  Circ Res       Date:  2018-01-05       Impact factor: 17.367

Review 9.  Adaptive immune cells in calcific aortic valve disease.

Authors:  Michael A Raddatz; Meena S Madhur; W David Merryman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-03       Impact factor: 4.733

10.  Cardiac Immunology: A New Era for Immune Cells in the Heart.

Authors:  Arzuhan Koc; Esra Cagavi
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.